Furthermore, in addition to highly methylated AKR1B1, RASGRF2 and CRMP1 gene promoters, BNIP3, GSTP1, HOXA5 and PAX6 gene promoters were also methylated in ER-positive and HER2-negative breast cancer with ALNM, which may serve as candidate methylation biomarkers. This evidence concerns the gene ERBB2 and breast carcinoma.